Current concepts in the assessment and treatment of hepatic encephalopathy.
Cash, W J McConville, P McDermott, E McCormick, P A Callender, M E McDougall, N I
Cash, W J
McConville, P
McDermott, E
McCormick, P A
Callender, M E
McDougall, N I
Advisors
Editors
Other Contributors
Date
2012-02-01T10:30:15Z
Date Submitted
Keywords
Other Subjects
Subject Mesh
Hepatic Encephalopathy/diagnosis/etiology/*therapy
Humans
Hyperammonemia/metabolism
Liver Cirrhosis/*complications/diagnosis
Humans
Hyperammonemia/metabolism
Liver Cirrhosis/*complications/diagnosis
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
Hepatic encephalopathy (HE) is defined as a metabolically induced, potentially reversible, functional disturbance of the brain that may occur in acute or chronic liver disease. Standardized nomenclature has been proposed but a standardized approach to the treatment, particularly of persistent, episodic and recurrent encephalopathy associated with liver cirrhosis has not been proposed. This review focuses on the pathogenesis and treatment of HE in patients with cirrhosis. The pathogenesis and treatment of hepatic encephalopathy in fulminant hepatic failure is quite different and is reviewed elsewhere.
Language
eng
ISSN
1460-2393 (Electronic)
1460-2393 (Linking)
1460-2393 (Linking)
eISSN
ISBN
DOI
10.1093/qjmed/hcp152
PMID
19903725